Combining proprietary biopharmaceutical technologies with seasoned industry leaders to capitalize on the transformational impact of Cannabis in the high-growth skincare, beauty, and personal care sector.
America's CBD market is projected to grow from $591M in 2018 to $22B by 2022.
(Source: Brightfield Group)
Led by regulatory evolution, new medical research, and perception shift, the acceleration of the CBD industry in the United States is creating a new market space with opportunities for growth.
With the legalization of hemp derived CBD recently approved by Congress, CBD’s disruption to the health and wellness industry has begun, as products infused with cannabis-inspired ingredients can feature effective medicinal, restorative, and therapeutic benefits.
LBE believes CBD-inspired beauty and personal care opportunities in the health and wellness, sustainability, and social impact spaces represent one of the great industry growth trends in the coming years.
These ‘pharma lite’ businesses are uniquely attractive, as they combine strong demographic growth and pharmaceutical industry profitability, without the high regulatory and capital expenditure costs.
We have assembled seasoned industry leaders with partners in biopharmaceutical technology, to develop our emerging brands to be well positioned in the growing CBD marketplace.
CBD, also known as cannabidiol, is a chemical compound derived from hemp (cannabis sativa plant), which is a natural non-psychoactive, separate from its more commonly known psychoactive counterpart, THC. The derivation of CBD from hemp has been legalized in the December 2018 Farm Bill passed by the US Congress.
This website is intended solely to provide information regarding LBEquity & Associates’ potential financing capabilities for prospective portfolio companies. The information provided on this website, including information regarding LBEquity & Associates’ current and historical portfolio companies, is not intended to recommend any company or investment described herein and is not an offer or sale of any security or investment product or investment advice. In any event, past performance is not a guarantee of future results and it should not be assumed that results for portfolio investments will be achieved for other investments. Representative investments are not to be considered a complete list of all investments made or currently held by LBEquity & Associates funds. LBEquity & Associates provides investment advisory services only to the privately offered LBEquity & Associates funds. LBEquity & Associates does not solicit or make its services available to the public or other advisory clients. The "Limited Partners Web Site" is solely for the use of existing limited partners of investment funds sponsored by LBEquity & Associates and is intended to provide electronic copies of information that existing limited partners have received already as investors in LBEquity & Associates funds. In the United States of America, LBEquity & Associates operates as an exempt reporting advisor. This website is intended solely to provide information regarding LBEquity & Associates’ potential financing capabilities for prospective portfolio companies.